Geneva, Jan. 12 -- International Clinical Trials Registry received information related to the study (ChiCTR2500115805) titled 'Model-Guided Dose Optimization of Cefoperazone-Sulbactam and Levofloxacin for Pneumonia and Urinary Tract Infections in Patients with Hepatic Dysfunction' on Dec. 31, 2025.
Study Type: Interventional study
Study Design:
Parallel
Primary Sponsor: Chun' an County First People's Hospital
Condition:
Hepatic dysfunction complicated with pneumonia and urinary tract infection
Intervention:
Model-guided Group:Following randomization, a 7-day observation period was established. For each patient, blood samples were required to be collected within 24 hours after the initial administration to evaluate the practical im...